Mark Jensen
Mark Jensen is the chair of the board of directors for 23andMe and played a key role in the company's recent decision to file for Chapter 11 bankruptcy protection, aiming to facilitate a court-supervised sale process to maximize the business's value.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 7.00 | 0.04% | +0% | 67,886,011 | 29,036 | $2,700,000 | 1,155$ |
| Totals | 1 | 67,886,011 | 29,036 | $2,700,000 | 1,155$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United Kingdom:
Mark Jensen is the board chairman of 23andMe who commented on the transaction with Regeneron.
7
United States:
Mark Jensen, the board chair of 23andMe, stated that data privacy will be an important consideration in any potential transaction.
7
Israel:
Mark Jensen stated that a court-supervised sale process is the best way to maximize the value of the business.
5
Australia:
Mark Jensen, the board chair, stated that the bankruptcy process was the best path forward for 23andMe.
6
United States:
Mark Jensen, Chair and member of the Special Committee of the Board of Directors, said in a statement.
6
United States:
Mark Jensen, chair and member of the Special Committee of the board of directors, stated that a court-supervised sale process is the best path forward for 23andMe.
5
United States:
Mark Jensen is the chair and member of the Special Committee of the board of directors.
5